These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3947404)

  • 1. [Study of peptide degradation in the serum by 1H-NMR].
    Isakova OL; Sepetov NF; Bespalova ZhD; Bushuev VN; Vinogradov VA
    Bioorg Khim; 1986 Jan; 12(1):106-11. PubMed ID: 3947404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of 1H-NMR-spectroscopy for the study of peptide degradation by angiotensin-converting enzyme].
    Sakharov IIu; Isakova OL; Sepetov NF; Bespalova ZhD; Ruuge EK
    Biokhimiia; 1987 Feb; 52(2):311-6. PubMed ID: 3032288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of dalargin].
    Kalenikova EI; Dmitrieva OF; Korobov NV; Zhukovskiĭ SV; Tishchenko VA
    Vopr Med Khim; 1988; 34(1):75-83. PubMed ID: 3369130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Degradation of dalargin and its analogs in the brush border membranes of rat enterocytes studied by 1H-NMR spectroscopy].
    Sepetov NF; Isakova OL; Pekelis BL; Suraeva NM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):86-9. PubMed ID: 3801146
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies to dalargin--a synthetic analog of enkephalins.
    Ananyeva NM; Tischenko VA; Bespalova JD; Pekelis BL; Yakubov LZ; Vinogradov VA; Rokhlin OV; Titov MI
    Immunol Lett; 1988 Aug; 18(4):269-73. PubMed ID: 3182012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.
    Kerchner GA; Geary LE
    J Pharmacol Exp Ther; 1983 Jul; 226(1):33-8. PubMed ID: 6345754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inhibitory effect of the synthetic leu-enkephalin analog dalargin on carcinogenesis].
    Anisimov VN; Bortkevich SM
    Vopr Onkol; 1990; 36(5):556-9. PubMed ID: 2378078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of dalargin and its metabolism during intranasal administration to rats].
    Vinogradov VA; Kalenikova EI; Sokolov AS
    Biull Eksp Biol Med; 1988 Jul; 106(7):48-50. PubMed ID: 3401577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of an opioid peptide on the healing of experimental myocardial infarct].
    Afonskaia NI; Il'inskiĭ OB; Kondalenko VF; Spevak SE; Cherpachenko NM
    Biull Eksp Biol Med; 1986 Dec; 102(12):754-7. PubMed ID: 3801632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dalargin--an opioid-like peptide with peripheral action].
    Korobov NV
    Farmakol Toksikol; 1988; 51(4):35-8. PubMed ID: 3191970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man].
    Zaĭtsev SV; Vinogradov VA; Sergeeva MG; Dmitrieva OF; Ivanikov IO
    Biull Eksp Biol Med; 1986 Jun; 101(6):702-4. PubMed ID: 3730557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalin degradation by human erythrocytes and hemolysates studied using 1H NMR spectroscopy.
    Vandenberg JI; King GF; Kuchel PW
    Arch Biochem Biophys; 1985 Nov; 242(2):515-22. PubMed ID: 4062293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of the antistressor effect of D-Ala(2)-Leu(5)-Arg(6)-enkephalin].
    Lishmanov IuB; Maslov LN; Titov MI
    Biull Eksp Biol Med; 1985 Sep; 100(9):268-70. PubMed ID: 2994775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    Weinberger SB; Martinez JL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):129-35. PubMed ID: 2902210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of ammonium formate-catalytic transfer hydrogenation. Part V (1). Transfer hydrogenolysis of peptides containing p-chlorophenylalanine as a convenient method for preparation of deuterium labeled peptides.
    Anwer MK; Porter RA; Spatola AF
    Int J Pept Protein Res; 1987 Oct; 30(4):489-97. PubMed ID: 2962959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two gamma-bends in the backbone conformation of [D-Ala2]-leucine enkephalin in solution.
    Dhingra MM; Saran A
    Biopolymers; 1989 Jul; 28(7):1271-85. PubMed ID: 2775841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function of the endogenous opioid system in hypoxic hypoxia].
    Zoloev GK
    Fiziol Zh SSSR Im I M Sechenova; 1989 Apr; 75(4):575-8. PubMed ID: 2527170
    [No Abstract]   [Full Text] [Related]  

  • 18. Refinement of conformational preferences of Leu enkephalin and Tyr-Gly-Gly-Phe by 15N n.m.r.: chemical shifts and vicinal coupling constants.
    Garbay-Jaureguiberry C; Marion D; Fellion E; Roques BP
    Int J Pept Protein Res; 1982 Nov; 20(5):443-50. PubMed ID: 7174208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-ECD determination of the enzymatic hydrolysis of [leu]- and [met]enkephalin in rat plasma.
    Shibanoki S; Weinberger SB; Ishikawa K; Martinez JL
    Prog Clin Biol Res; 1990; 328():253-6. PubMed ID: 1968263
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience-dependent regulation of Leu-enkephalin hydrolysis in rat plasma.
    Schulteis G; Martinez JL
    Peptides; 1993; 14(2):161-7. PubMed ID: 8483796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.